Biolife Sciences Inc
OTC:BLFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
LG Electronics India Ltd
NSE:LGEINDIA
|
IN |
Biolife Sciences Inc
Total Assets
Biolife Sciences Inc
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biolife Sciences Inc
OTC:BLFE
|
Total Assets
$193.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Assets
$43.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Assets
$13.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Assets
$47.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Assets
$86.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Assets
$20.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Biolife Sciences Inc
Glance View
Bio Life Sciences, Inc. engages in the development of mobile applications and Voice over Internet Protocol (VoIP) services. The company is headquartered in New York City, New York. The company went IPO on 2005-04-25. The Company’s core business develops, licenses and distributes antimicrobial products, non-contract human temperature screening technology and touchless vending products. Its technology solutions include Antimicrobial Copper Air Filters, Non-contact Human Temperature Screening, Ultraviolet Sterilization, and Next-Generation Vending Machines. Its BioLife Antimicrobial Copper Air Cleaner fabric filters capture and kill bacteria that passes through air vents and releases clean air along with deposits of copper ions. BioLife Intelligent Touchless Vending and Marketplaces that provides digital advertising and digital vending machines serving a range of personal protective equipment and antimicrobial products. Its non-contract human temperature screening technology solutions detect subjects’ body temperature.
See Also
What is Biolife Sciences Inc's Total Assets?
Total Assets
193.7k
USD
Based on the financial report for Nov 30, 2021, Biolife Sciences Inc's Total Assets amounts to 193.7k USD.
What is Biolife Sciences Inc's Total Assets growth rate?
Total Assets CAGR 1Y
-27%
Over the last year, the Total Assets growth was -27%.
